
Weight-loss medications
Foundayo vs Rybelsus: 9.2% vs 5.3% average weight loss over 52 weeks in a type 2 diabetes trial. Compare side effects and UK prescribing.

Weight-loss medications
Foundayo can make you feel tired. Learn how appetite changes, dehydration, and brain effects may contribute, plus practical ways to improve your energy.

Weight-loss medications
You might not be losing weight on Foundayo because the dose isn't lowering hunger enough, you've reached a plateau, or your eating habits haven't changed.

Weight-loss medications
Foundayo (orforglipron) is a daily GLP-1 pill for weight loss (11.2%) with no fasting requirements. MHRA approved for UK use on August 10th 2026.

Weight-loss medications
Wegovy leads to more weight loss than Foundayo on average, but some people may prefer a daily tablet over weekly injections. Read how they compare.

Weight-loss medications
Current UK guidance says to continue Wegovy or Mounjaro before surgery. See what the GLIMPSE study found and what to tell your anaesthetist.

Weight-loss medications
GLP-1 medicines haven't been shown to cause brain damage. Learn what Wernicke reports reveal about thiamine deficiency and eating habits.

Weight-loss medications
Most prescribed antidepressants can usually be taken with Foundayo. Learn about interactions, side effects, and when to contact your prescriber.

Weight-loss medications
Foundayo (orforglipron) may be suitable if you have epilepsy, but it shouldn't be used with carbamazepine or phenytoin. Find out more here.

Weight-loss medications
You can take Foundayo after having breast cancer, as long as you're no longer receiving active treatment and are in complete remission. Find out more here.